Published in Expert Opin Biol Ther on January 05, 2011
Oral monosaccharide therapies to reverse renal and muscle hyposialylation in a mouse model of GNE myopathy. Mol Genet Metab (2012) 0.99
Recent progress in satellite cell/myoblast engraftment -- relevance for therapy. FEBS J (2013) 0.96
Options for tracking GFP-Labeled transplanted myoblasts using in vivo fluorescence imaging: implications for tracking stem cell fate. BMC Biotechnol (2014) 0.92
Molecular and cell-based therapies for muscle degenerations: a road under construction. Front Physiol (2014) 0.92
Macrophages improve survival, proliferation and migration of engrafted myogenic precursor cells into MDX skeletal muscle. PLoS One (2012) 0.89
Myogenesis and muscle regeneration. Histochem Cell Biol (2012) 0.88
Efficient Restoration of the Dystrophin Gene Reading Frame and Protein Structure in DMD Myoblasts Using the CinDel Method. Mol Ther Nucleic Acids (2016) 0.86
Murine and human myogenic cells identified by elevated aldehyde dehydrogenase activity: implications for muscle regeneration and repair. PLoS One (2011) 0.85
Sources for skeletal muscle repair: from satellite cells to reprogramming. J Cachexia Sarcopenia Muscle (2013) 0.83
UDP-GlcNAc 2-Epimerase/ManNAc Kinase (GNE): A Master Regulator of Sialic Acid Synthesis. Top Curr Chem (2015) 0.83
The emerging role of viral vectors as vehicles for DMD gene editing. Genome Med (2016) 0.76
Converting pathological cells to therapeutic ones: an odyssey through pluripotency. Mol Ther (2012) 0.75
Injectable biomimetic liquid crystalline scaffolds enhance muscle stem cell transplantation. Proc Natl Acad Sci U S A (2017) 0.75
Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther (2007) 3.69
Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Mol Ther (2011) 2.06
Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patients. Mol Ther (2013) 1.63
Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J Neuropathol Exp Neurol (2006) 1.37
First test of a "high-density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up. Neuromuscul Disord (2006) 1.37
Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation. Mol Ther (2012) 1.33
Exercise improves the success of myoblast transplantation in mdx mice. Neuromuscul Disord (2006) 1.19
Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol Ther (2004) 1.17
Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Mol Ther (2013) 1.16
Nucleofection of muscle-derived stem cells and myoblasts with phiC31 integrase: stable expression of a full-length-dystrophin fusion gene by human myoblasts. Mol Ther (2004) 1.15
Intramuscular transplantation of human postnatal myoblasts generates functional donor-derived satellite cells. Mol Ther (2010) 1.13
Resetting the problem of cell death following muscle-derived cell transplantation: detection, dynamics and mechanisms. J Neuropathol Exp Neurol (2003) 1.13
Myoblast transplantation: the current status of a potential therapeutic tool for myopathies. J Muscle Res Cell Motil (2003) 1.10
Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteins. Biochem Biophys Res Commun (2004) 1.08
Decidualization and maintenance of a functional prostaglandin system in human endometrial cell lines following transformation with SV40 large T antigen. Mol Hum Reprod (2006) 1.04
Past, present and future of myoblast transplantation in the treatment of Duchenne muscular dystrophy. Pediatr Transplant (2010) 1.03
RCAS1 is associated with ductal breast cancer progression. Biochem Biophys Res Commun (2002) 0.99
Laminin-111: a potential therapeutic agent for Duchenne muscular dystrophy. Mol Ther (2010) 0.98
Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans. Exp Neurol (2002) 0.98
Inhibiting myostatin with follistatin improves the success of myoblast transplantation in dystrophic mice. Cell Transplant (2008) 0.98
Ischemic central necrosis in pockets of transplanted myoblasts in nonhuman primates: implications for cell-transplantation strategies. Transplantation (2007) 0.95
Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models. Mol Ther (2007) 0.94
Improved success of myoblast transplantation in mdx mice by blocking the myostatin signal. Transplantation (2005) 0.93
Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model. J Cell Biol (2003) 0.92
Endonucleases: tools to correct the dystrophin gene. J Gene Med (2011) 0.92
The paracrine effect: pivotal mechanism in cell-based cardiac repair. J Cardiovasc Transl Res (2010) 0.90
Dystrophin expression following the transplantation of normal muscle precursor cells protects mdx muscle from contraction-induced damage. Cell Transplant (2010) 0.90
Intramuscular transplantation of myogenic cells in primates: importance of needle size, cell number, and injection volume. Cell Transplant (2013) 0.89
Macrophages improve survival, proliferation and migration of engrafted myogenic precursor cells into MDX skeletal muscle. PLoS One (2012) 0.89
A Potential New Therapeutic Approach for Friedreich Ataxia: Induction of Frataxin Expression With TALE Proteins. Mol Ther Nucleic Acids (2013) 0.89
Myoblast survival enhancement and transplantation success improvement by heat-shock treatment in mdx mice. Transplantation (2004) 0.86
Dynamics of the early immune cellular reactions after myogenic cell transplantation. Cell Transplant (2002) 0.86
Expression of dog microdystrophin in mouse and dog muscles by gene therapy. Mol Ther (2010) 0.86
Treatment with anti-CD154 antibody and donor-specific transfusion prevents acute rejection of myoblast transplantation. Transplantation (2002) 0.85
Transplanted myoblasts can migrate several millimeters to fuse with damaged myofibers in nonhuman primate skeletal muscle. J Neuropathol Exp Neurol (2011) 0.85
Targeted Gene Addition of Microdystrophin in Mice Skeletal Muscle via Human Myoblast Transplantation. Mol Ther Nucleic Acids (2013) 0.84
Experimental and therapeutic approaches to muscular dystrophies. Curr Opin Neurol (2002) 0.83
Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice. Mol Ther (2010) 0.83
Use of repeating dispensers to increase the efficiency of the intramuscular myogenic cell injection procedure. Cell Transplant (2006) 0.82
Losartan enhances the success of myoblast transplantation. Cell Transplant (2011) 0.82
Ganglioside GM3 levels are altered in a mouse model of HIBM: GM3 as a cellular marker of the disease. PLoS One (2010) 0.82
Cell therapies for inherited myopathies. Curr Opin Rheumatol (2003) 0.81
Assessment of a symptomatic Duchenne muscular dystrophy carrier 20 years after myoblast transplantation from her asymptomatic identical twin sister. Neuromuscul Disord (2013) 0.81
Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerism. Am J Transplant (2004) 0.81
Growth factor coinjection improves the migration potential of monkey myogenic precursors without affecting cell transplantation success. Cell Transplant (2009) 0.80
Electroporation as a method to induce myofiber regeneration and increase the engraftment of myogenic cells in skeletal muscles of primates. J Neuropathol Exp Neurol (2013) 0.80
Intramuscular Transplantation of Muscle Precursor Cells over-expressing MMP-9 improves Transplantation Success. PLoS Curr (2011) 0.79
Cell therapy in muscular dystrophies: many promises in mice and dogs, few facts in patients. Expert Opin Biol Ther (2015) 0.79
Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector. Cell Transplant (2002) 0.79
Electrotransfer of the full-length dog dystrophin into mouse and dystrophic dog muscles. Hum Gene Ther (2010) 0.79
Fibrin gel improves the survival of transplanted myoblasts. Cell Transplant (2011) 0.79
Central tolerance to myogenic cell transplants does not include muscle neoantigens. Transplantation (2008) 0.78
Development and characterization of a simian virus 40 immortalized bovine endometrial stromal cell line. Endocrinology (2008) 0.78
Real-time imaging of myoblast transplantation using the human sodium iodide symporter. Biotechniques (2005) 0.77
Effects of vitamin C on cytotherapy-mediated muscle regeneration. Cell Transplant (2012) 0.77
Administration of a soluble activin type IIB receptor promotes the transplantation of human myoblasts in dystrophic mice. Cell Transplant (2012) 0.77
Induction of tolerance across fully mismatched barriers by a nonmyeloablative treatment excluding antibodies or irradiation use. Cell Transplant (2006) 0.77
1,25-dihydroxyvitamin D3 increases the transplantation success of human muscle precursor cells in SCID mice. Cell Transplant (2007) 0.77
Ex vivo modification of cells to induce a muscle-based expression. Curr Gene Ther (2006) 0.77
A first semimanual device for clinical intramuscular repetitive cell injections. Cell Transplant (2010) 0.77
Percutaneous versus surgical delivery of autologous myoblasts after chronic myocardial infarction: an in vivo cardiovascular magnetic resonance study. Catheter Cardiovasc Interv (2010) 0.76
AG490 improves the survival of human myoblasts in vitro and in vivo. Cell Transplant (2012) 0.76
Necrosis, sarcolemmal damage and apoptotic events in myofibers rejected by CD8+ lymphocytes: Observations in nonhuman primates. Neuromuscul Disord (2012) 0.76
Efficacy and site-specificity of adenoviral vector integration mediated by the phage φC31 integrase. Hum Gene Ther Methods (2012) 0.76
Therapeutic effects of exon skipping and losartan on skeletal muscle of mdx mice. Pathol Int (2014) 0.76
Myoblast transplantation: a possible surgical treatment for a severe pediatric disease. Surg Today (2010) 0.76
Preservation of muscle spindles in a 27-year-old Duchenne muscular dystrophy patient: importance for regenerative medicine strategies. Muscle Nerve (2010) 0.75
First study of intra-arterial delivery of myogenic mononuclear cells to skeletal muscles in primates. Cell Transplant (2014) 0.75
Online Manuscript Processing for Cell Transplantation. Cell Transplant (2006) 0.75
Generation of lentiviral vectors for use in skeletal muscle research. Methods Mol Biol (2012) 0.75
Myopathy in a rhesus monkey with biopsy findings similar to human sporadic inclusion body myositis. Neuromuscul Disord (2012) 0.75